Insider Transactions Reported by 12 Insiders of Chemomab Therapeutics Ltd.

Symbol
CMMB on Nasdaq
Location
Tel Aviv

There are no Buy or Sell transactions made by insiders since 28 Dec 2024

Chemomab Therapeutics Ltd. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
OrbiMed Israel GP Ltd. 10%+ Owner $10.1M 03 Jan 2023
Adi Mor Chief Scientific Officer, Director $2.86M 03 Jan 2023
Neil Cohen Director $50.3K 16 Mar 2023
Sigal Fatal Chief Financial Officer $26.2K 14 Jun 2023
Dale R. Pfost Chief Executive Officer, Director $12.6K 14 Mar 2022
Donald Marvin Executive VP, CFO & COO $10.1K 16 Mar 2022
Joel Michael Maryles Director $7.2K 24 May 2022
Nissim Darvish Director $6.03K 14 Jun 2023
Matthew B. Frankel Chief Medical Officer 14 Nov 2022
Claude Nicaise Director 16 Mar 2023
Alan Moses Director 16 Mar 2023
Jill M. Quigley Director 16 Jun 2023

Recent Insider Transactions by Companies or Individuals for Chemomab Therapeutics Ltd.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.